Current challenges in treating MRSA: what are the options?

Treatment challenges in the management of complicated skin and soft-tissue infections

(2010) B.I. Eisenstein   CLINICAL MICROBIOLOGY AND INFECTION

Pharmacokinetics and Pharmacodynamics of Ceftobiprole, an Anti-MRSA Cephalosporin with Broad-Spectrum Activity

(2009) Bindu Murthy et al.   CLINICAL PHARMACOKINETICS

Etiology and treatment of community-associated methicillin-resistant Staphylococcus aureus

(2008) R. A. Herman et al.   AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY

Antimicrobial Activities of Ceftaroline and ME1036 Tested against Clinical Strains of Community-Acquired Methicillin-Resistant Staphylococcus aureus

(2008) H. S. Sader et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Pharmacodynamics of the Antibacterial Effect and Emergence of Resistance to Tomopenem, Formerly RO4908463/CS-023, in an In Vitro Pharmacokinetic Model of Staphylococcus aureus Infection

(2008) A. P. MacGowan et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

First Report of cfr-Mediated Resistance to Linezolid in Human Staphylococcal Clinical Isolates Recovered in the United States

(2008) R. E. Mendes et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Molecular epidemiology of clinically significant antibiotic resistance genes

(2008) P M Hawkey   BRITISH JOURNAL OF PHARMACOLOGY

Dalbavancin: a Novel Once-Weekly Lipoglycopeptide Antibiotic

(2008) L. D. Saravolatz et al.   CLINICAL INFECTIOUS DISEASES

Colonization, Fomites, and Virulence: Rethinking the Pathogenesis of Community-Associated Methicillin-Resistant Staphylococcus aureus Infection

(2008) L. G. Miller et al.   CLINICAL INFECTIOUS DISEASES

Vancomycin-Resistant Staphylococcus aureus in the United States, 2002-2006

(2008) D. M. Sievert et al.   CLINICAL INFECTIOUS DISEASES

A Randomized, Double-Blind Trial Comparing Ceftobiprole Medocaril with Vancomycin plus Ceftazidime for the Treatment of Patients with Complicated Skin and Skin-Structure Infections

(2008) G. J. Noel et al.   CLINICAL INFECTIOUS DISEASES

Comparison of Both Clinical Features and Mortality Risk Associated with Bacteremia due to Community-Acquired Methicillin-Resistant Staphylococcus aureus and Methicillin-Susceptible S. aureus

(2008) J.-L. Wang et al.   CLINICAL INFECTIOUS DISEASES

Epidemiology of Methicillin‐ResistantStaphylococcus aureus

(2008) Helen W. Boucher et al.   CLINICAL INFECTIOUS DISEASES

Telavancin Versus Vancomycin for the Treatment of Complicated Skin and Skin‐Structure Infections Caused by Gram‐Positive Organisms

(2008) Martin E. Stryjewski et al.   CLINICAL INFECTIOUS DISEASES

New antimicrobial agents for the treatment of Gram-positive bacterial infections

(2008) D.Y. Aksoy et al.   CLINICAL MICROBIOLOGY AND INFECTION

Pharmacokinetic and pharmacodynamic profile of ceftobiprole

(2008) Thomas P. Lodise et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Oritavancin: a new promising agent in the treatment of infections due to Gram-positive pathogens

(2008) Garyphallia Poulakou et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Bacteremia and Infective Endocarditis Caused by a Non-Daptomycin-Susceptible, Vancomycin-Intermediate, and Methicillin-Resistant Staphylococcus aureus Strain in Taiwan

(2008) Y.-T. Huang et al.   JOURNAL OF CLINICAL MICROBIOLOGY

The Arginine Catabolic Mobile Element and Staphylococcal Chromosomal CassettemecLinkage: Convergence of Virulence and Resistance in the USA300 Clone of Methicillin‐ResistantStaphylococcus aureus

(2008) Binh An Diep et al.   JOURNAL OF INFECTIOUS DISEASES

Epidemic community-associated methicillin-resistant Staphylococcus aureus: Recent clonal expansion and diversification

(2008) A. D. Kennedy et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The role of virulence determinants in community-associated MRSA pathogenesis

(2008) Binh An Diep et al.   TRENDS IN MICROBIOLOGY